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GFP
PhoAFragments of large membrane proteins have the potential to facilitate structural analysis by NMR, but their
folding state remains a concern. Here we determined the quality of folding upon heterologous expression
for a series of N- or C-terminally truncated fragments of the human Y4 G-protein coupled receptor,
amounting to six different complementation pairs. As the individual fragments lack a speciﬁc function that
could be used to ascertain proper folding, we instead assessed folding on a basic level by studying their mem-
brane topology and by comparing it to well-established structural models of GPCRs. The topology of the frag-
ments was determined using a reporter assay based on C-terminal green ﬂuorescent protein- or alkaline
phosphatase-fusions. N-terminal fusions to Lep or Mistic were used if a periplasmic orientation of the
N-terminus of the fragments was expected based on predictions. Fragments fused to Mistic expressed at
comparably high levels, whereas Lep fusions were produced to a much lower extent. Though none of the frag-
ments exclusively adopted one orientation, often the correct topology predominated. In addition, systematic
analysis of the fragment series suggested that the C-terminal half of the Y4 receptor is more important for
adopting the correct topology than the N-terminal part. Using the detergent dodecylphosphocholine, selected
fragments were solubilized from the membrane and proved sufﬁciently stable to allow puriﬁcation. Finally, as
a ﬁrst step toward reconstituting a functional receptor from two fragments, we observed a physical interaction
between complementing fragments pairs upon co-expression.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
G-protein coupled receptors are of tremendous importance in signal
transduction, and hence play a pivotal role in pharmaceutical sciences
and serve as targets for many successful drugs. The crystal structure of
bovine rhodopsin was published in the year 2000 and since then we
have witnessed an increasing number of new GPCR structures [1–7].
All these structures were determined by X-ray crystallography.
NMR spectroscopy has the additional advantage over crystallography
of being able to report on dynamics of proteins, but so far no structures of
GPCRswere determined using this method. The recently published struc-
tures of sensory rhodopsin [8] and proteorhodopsin [9], though not true
GPCRs, proved that themethod in principle can determine solution struc-
tures of large alpha-helicalmembrane proteins to high resolution, provid-
ed that spectra of good quality can be measured. The latter requirement
so far has largely impeded the progress in NMR of true GPCRs.
Our group has focused on the study of large fragments of GPCRs,
comprising two or more transmembrane (TM) helices [10]. We study
these fragments in order to learn about the folding of GPCRs, in partic-
ular to learn about the mechanism of TM bundle assembly, possibly+41 44 6356834.
+41 44 6356882.
tsma), oliver.zerbe@oci.uzh.ch
rights reserved.from complementing fragments (the so-called split-receptors). The
fragments could also facilitate assignments in the entire receptors. The
fragments are produced recombinantly in Escherichia coli in various
ﬂavors of isotope labeling. Recently we could demonstrate that a frag-
ment comprising the ﬁrst two TM segments, further on referred to as
TM1–2, of the yeast GPCR Ste2p adopts a well-deﬁned secondary struc-
ture in LPPG micelles [11]. Moreover, NOEs coding for interhelical con-
tacts involving methyl groups could be detected indicating that the
Ste2p TM1–2 fragment adopts a deﬁned tertiary structure. Due to the
increase of the overall correlation time for larger protein-detergent
complexes, resulting in broader lines, solution NMR experiments for
resonance assignments become more difﬁcult. The use of protein frag-
ments allows differential labeling in order to reduce the complexity of
spectra and to facilitate resonance assignments for these challenging
systems. Unfortunately, the production of well-folded fragments har-
boring several TM segments is problematic. Expression in E. coli as inclu-
sion bodies often results in high yields but requires refolding, which
is challenging for alpha-helical membrane proteins. Alternatively, at-
tempts to express the protein in a folded state in the membrane often
lead to decreased yields with increasing size [12,13].
To obtain rapid information aboutwhich fragments are likely suitable
for more in-depth NMR studies, we herein present an auxiliary method
for investigating the folding state of GPCR fragments. Though in general
the folding quality of the protein produced is best determined using an
assay that measures its speciﬁc activity, here this is not possible as the
Fig. 1. Schematic representation of the truncated versions of the human Y4 receptor
used in this study. Constructs are divided in C-terminal and N-terminal truncations.
Mistic and Lep (blue and gray triangles) were used as fusion proteins to obtain an
Nout topology for the Y4 receptor fragments where needed and to enhance expression
levels of fragments with an Nin topology (Mistic only, blue triangles). GFP and PhoA
were used as C-terminal reporter proteins for cellular localizations (indicated by a
circle).
3056 J. Marino et al. / Biochimica et Biophysica Acta 1818 (2012) 3055–3063individual fragments do not carry any function.We instead assessed the
folding quality by performing a systematic topological survey of the
fragments and determining their agreement with a model derived
from the high-resolution structure of rhodopsin [14]. The GPCR studied
here, the Y4 receptor, presents a human GPCR targeted by the neuro-
hormones of the neuropeptide Y (NPY) family [15–17].
In this work we have systematically truncated one alpha-helix of the
Y4 receptor at a time from its N-terminus (here referred to as N-terminal
truncations) or from its C-terminus (referred to as C-terminal trunca-
tions), producing the six constructs in the series TM2–7, TM3–7 up to
TM7 and the six complementing constructs TM1, TM1–2 up to TM1–6,
respectively (Fig. 1). The topology of the fragments was subsequently
determined using the well-established GFP/PhoA reporter assay [18].
The fragments were fused to the C-terminus of Lep or Mistic when
appropriate, to enable a periplasmic location of the N-terminus of the
fragments. Lep contains the two N-terminal TM segments of the E. coli
leader peptidase, also known as Signal Peptidase I. Both Lep and Mistic
have been reported to facilitate an initial periplasmic orientation of pro-
teins fused to their C-terminus [19–21]. In addition, Mistic has been
suggested to enhance the expression of membrane proteins regardless
of the preferred orientation of the N-terminus of the respective protein
[22].
The study herein represents our ﬁrst attempt to investigate the fold-
ing state of heterologously produced GPCR fragments in a true mem-
brane environment. Moreover, we compare the use of two N-terminal
fusion proteins that have distinct modes of interaction with the E. coli
inner membrane. We believe that the knowledge derived from this
study will contribute to the design of fragments for self-assembly into
a functional split receptor with the future aim of developing this system
for structural studies by NMR. Accordingly, we demonstrate physical
interactions between co-expressed complementing fragment pairs of
the Y4 GPCR.
2. Materials and methods
2.1. Cloning of Y4 receptor fragments starting with TM1
The genes coding forMistic and Lepwere ampliﬁedby PCR introduc-
ing a 5′NdeI and 3′ BamHI restriction site; the twoDNA fragmentswere
then cloned in a pET21b vector (Novagen) between NdeI and BamHI
sites. The gene coding for the human Y4 receptor was ampliﬁed by
PCR introducing a 5′ BamHI site followed by a 3C protease cleavage
site (CTGGAAGTTCTGTTTCAGGGTCCG) and a 3′ XhoI site. The PCR
product was cloned between BamHI and XhoI into the pET21b vectors
harboring mistic or lep. These two vectors were used as PCR templates
for all the C-terminal truncations of the Y4 receptor. The Y4 receptor
fragments starting with TM1 were designed to have a Mistic-3C prote-
ase site or a Lep-3C protease site fused to their N-terminus and green
ﬂuorescent protein (GFP) or the alkaline phosphatase (PhoA) to their
C-terminus. The terminal residues of Mistic and Lep were E110 and
Q86, respectively, and terminal residues of the Y4 receptor fragments
are indicated in Suppl. Table 1. Gene fusions coding for Mistic or Lep
and Y4 receptor fragments starting with TM1 were cloned using
the FX cloning method [23] into derivatives of pBAD24 [24] containing
open reading frames for a 3C protease cleavage site, EGFP and a
decaHis-tag (pBXC3GH; [23]) or a linker sequence (VPDSYTQVASWTE
PFPFC [25], the mature alkaline phosphatase (Δ26-phoA) and a
decaHis-tag (pBXCAPH; this work). For each construct, 5 μl of the FX
cloning reaction was used to transform chemically competent E. coli
DH5α. All plasmids were sequence veriﬁed and used to transform
chemically competent E. coli SF100 cells [26].
2.2. Cloning of Y4 receptor fragments ending with TM7
The Y4 receptor fragments ending with TM7 were designed to have
Mistic or Lep fused to their N-terminus and green ﬂuorescent protein(GFP) or the alkaline phosphatase (PhoA) to their C-terminus. Deriva-
tives of pBXC3GH and pBXCAPH containing open reading frames coding
forMistic or Lep in fusionwith the full length Y4 receptor served as tem-
plates. These vectors were ampliﬁed using 5′ phosphorylated primers.
The reverse primer overlappedwith the sequence coding for the 3C pro-
tease site located after Mistic or Lep. The forward primers overlapped
with the starting positions in the Y4 receptor indicated in Suppl. Table
1. PCR products were digested with DpnI to remove the template vec-
tors and subsequently gel puriﬁed. 50 ng of DNA in a volume of 8 μl
was supplemented with 1 μl of 10X T4 ligase buffer and 1 μl of T4
DNA ligase (1U) and subsequently incubated for 1 h at RT. After heat-
inactivating the T4 ligase for 20 min at 65 °C, 5 μl of the ligation reaction
was used to transform DH5α cells. All constructs were sequence-
veriﬁed and transformed to E. coli SF100 cells.
2.3. Cloning of EmrE and its mutants
The gene encoding for thewild-type EmrEwas ampliﬁed fromgeno-
mic DNA of E. coli MC1061 by PCR using primers compatible with the
FX cloning method. The EmrE mutant R29G/R82S [27] was obtained
by overlapping PCRs and cloned in pBXC3GH and pBXCAPH using FX
cloning.
3057J. Marino et al. / Biochimica et Biophysica Acta 1818 (2012) 3055–30632.4. Cloning of fragments pairs for co-expression
Individual genes coding for the complementation pairs TM1–3/
TM4–7 and TM1–5/TM6–7 were manipulated in the pBXC3GH vector
to: 1) contain a second 3C protease site adjacent to the ﬁrst site
between Mistic and the fragment; 2) remove the 3C protease site be-
tween the fragment and GFP; and 3) remove the His-tag for TM4–7
and TM6–7. Subsequently, the constructs were PCR ampliﬁed intro-
ducing 5′ NcoI and 3′ NotI restriction sites (Mistic-TM1–3-GFP-His
and Mistic-TM1–5-GFP-His) or 5′ NdeI and 3′ PacI restriction sites
(Mistic-TM4–7-GFP and Mistic-TM6–7-GFP). The PCR products coding
for the complementation pairs were then cloned in one pCDFDuet-1
vector (Novagen) to allow co-expression. In addition, genes coding for
Mistic-TM4–7-GFP and Mistic-TM6–7-GFP were also cloned in the
pCDFDuet-1 vectors without the gene coding for their complementa-
tion partner. These constructs served as negative controls. All vectors
were sequence-veriﬁed.
2.5. GFP ﬂuorescence determination in whole cells
Overnight cultures were started from single colonies on LB agar
plates and grown in 0.7 ml LB supplemented with ampicillin (LB-amp)
at 37 °C with vigorous shaking in 96 deep-well plates covered with a
gas-permeable seal. The overnight cultures were diluted 1:100 in
0.7 ml of LB-amp in a 96 deep-well plate. Cells were grown for 1 h at
37 °C after which the temperature of the incubator was set to 25 °C
and cultivation continued for 90 min after which the cells were induced
with 0.2% (w/v) arabinose. The approximate optical density of the
culture at this point was OD600=0.5. Cultivation was continued for
4 h and cells were harvested by centrifugation (3000 g, 10 min),
washed once with 500 μl of 50 mM KPi, pH 7.5, 150 mM NaCl and
resuspended in 300 μl of the same buffer. GFP ﬂuorescence of whole
cells was determined on 150 μl aliquots of these cell suspensions in a
black 96 well plate (Nunc, Denmark) using an Inﬁnite M1000 plate
reader (Tecan, Switzerland) with excitation at 485 nm and emission
at 535 nm. OD600 valueswere determined using50 μl of the cell suspen-
sion in a transparent 96well plate. All theﬂuorescence valueswere nor-
malized by OD600 and mean values were obtained by performing the
experiment at least twice using biological triplicates.
2.6. PhoA activity determination in whole cells
Overnight cultures and cultivation for expression were performed
as described above, except that cells were induced with 0.2% (w/v)
arabinose already after 1 h cultivation at 37 °C. At this stage the optical
density of the culture was approximately OD600=0.2. Growth was
subsequently continued for 1 h at 37 °C. Tenminutes before harvesting,
1 mM iodoacetamide was added to prevent oxidation of alkaline phos-
phatase located in the cytoplasm [28]. All buffers used afterwards
contained 1 mM iodoacetamide. Cells were washed at 4 °C with
300 μl of 1 M Tris–HCl, pH 8.0, and the OD600 was measured using
50 μl of the cell suspension in a transparent 96 well plate. The suspen-
sion was subsequently pelleted and cells were resuspended in 300 μl
of 1 M Tris–HCl, pH 8.0, containing 1.3 mM p-nitrophenyl-phosphate
and incubated in the dark at 37 °C until a yellow color developed.
Next, cells were pelleted (3000 g, 10 min, 4 °C) and the A420 of 150 μl
supernatant was determined using an Inﬁnite M1000 plate reader.
Mean activity valueswere obtained from two independent experiments
performed using biological triplicates. The absorbance at 420 nm was
normalized for the optical density at 600 nm.
2.7. In gel ﬂuorescence and solubilization assay
Protein samples were prepared as described elsewhere [29], except
that whole-cell samples corresponding to ~2 mg of protein were
used. Protein samples were analyzed by 15% SDS-PAGE, and in gelGFP ﬂuorescence was visualized with an LAS-3000 imaging system
(Fujiﬁlm, Switzerland) and AIDA software (Raytest, Germany). The
solubilization assay was done as described in [29] with the excep-
tion that 1 mM DTT was added to all the buffers. The detergents
dodecylphosphocholine (DPC), 1-myristoyl-2-hydroxy-sn-glycero-3-
phosphatidyl-glycerol (LMPG), n-dodecyl-β-d-maltoside (DDM),
octaethylene glycol monododecyl ether (C12E8; all purchased from
Anatrace, Canada) were added to a ﬁnal concentration of 1% (w/v).
2.8. Preparation of membrane vesicles
Overnight cultures of E. coli SF100 containing pBXC3GH deriva-
tives for selected Mistic-Y4 fusions were grown at 37 °C in Terriﬁc-
broth supplementedwith 0.1 mg/ml ampicillin (TB-amp). A 1% (v/v) in-
oculum was used to start growth in four 2.5 l bafﬂed ﬂasks each
containing 1 l TB-amp. Cells were grown for 1 h shaking at 37 °C after
which the temperature was lowered to 25 °C over the course of
90 min. After induction with 0.2% (w/v) arabinose, cultivation contin-
ued for 16 h. Cells were harvested by centrifugation at 6000 g for
15 min at 4 °C. The cell pellet was resuspended in ice-cold 50 mM KPi,
pH 7.5, 150 mMNaCl to anOD600 between 150 and 200. The suspension
was supplemented with lysozyme (1 mg/ml), DNase (20 μg/ml) and
MgCl (1 mM), homogenized and stirred for 1 h at 4 °C. Cells were
disrupted by three passes through a cooled pressure cell (Emulsiﬂex)
at 15 kPsi before protease inhibitor tablets (Roche) were added. Unbro-
ken cells were removed by centrifugation at 15,000 g for 15 min at 4 °C.
Subsequently, the membrane vesicles in the supernatant were pelleted
by centrifugation at 120,000 g at 4 °C for 1 h. Membrane vesicles were
homogenized in 50 mM KPi, pH 7.5, 150 mM NaCl, and 10% glycerol
using a Potter tube to a ﬁnal concentration of 1 g (wet weight) of mem-
brane vesicles per 2 ml buffer and immediately frozen in liquid nitrogen
and stored at−80 °C.
2.9. Puriﬁcation of the Mistic-Y4 fragment-GFP fusions
Membrane vesicles containing Y4 receptor fragments overexpressed
as fusions to Mistic (N-terminus) and GFP-His (C-terminus) were solu-
bilized at a concentration of 1 g vesicles (wet weight) to 10 ml solubili-
zation buffer (50 mMKPi, pH 7.5, 300 mMNaCl, 5% glycerol, 1 mMDTT,
1% (w/v) DPC and 15 mM imidazole), while stirring for 1 h at 4 °C. All
subsequent steps were performed at 4 °C. Insoluble material was re-
moved by centrifugation at 120,000 g for 30 min. The supernatants
were then incubated for 1 h with Ni-NTA resin (HIS-Select, Sigma,
Switzerland; ~0.6 ml resin per gram of vesicles) pre-equilibrated in
solubilization buffer. The resin was subsequently washed with ten col-
umn volumes (CV) 50 mM KPi, pH 7.5, 300 mM NaCl, 5% glycerol,
5 mM DPC and 30 mM imidazole. Proteins were eluted in 0.5 CV frac-
tions with 50 mM KPi, pH 7.5, 300 mM NaCl, 5% glycerol, 5 mM DPC
and 300 mM imidazole and subsequently injected into a Superdex
200 (10/300 GL) SEC column (GE), pre-equilibrated with wash buffer
devoid of imidazole. Peak fractions were subsequently re-injected.
2.10. Co-expression and co-puriﬁcation of fragments pairs
Co-expression of the complementing fragment pairs TM1–3/TM4–
7 and TM1–5/TM6–7 was done in E. coli BL21 (DE3) using the
pCDFDuet-1 derivatives described in Section 2.4. Overnight cultures
were started from single colonies and grown in 10 ml LB broth
supplemented with 0.1% streptomycin at 37 °C, shaking. The overnight
cultures were diluted 1:100 in 600 ml of TB (2 l/each fragment pair)
and cells were grown for 2 h at 37 °C, shaking. Subsequently the tem-
perature was lowered to 25 °C over the course of 1 h, cultures were in-
duced with 0.2 mM IPTG and cultivation was continued for 16 h. Cells
were harvested and membrane vesicles were prepared as described
in Section 2.8. Puriﬁcation of the fragments pairs was performed as de-
scribed in Section 2.9, except that all buffers contained 10% glycerol and
3058 J. Marino et al. / Biochimica et Biophysica Acta 1818 (2012) 3055–3063150 mMNaCl. In addition, the Ni-NTA resin (~0.5 ml per gr membrane
vesicles) was washed more extensively, using four times ten CV of
washing buffer (50 mM KPi, pH 7.5, 150 mM NaCl, 10% glycerol,
5 mMDPC), supplemented with 30, 5, 30 and 5 mM imidazole, respec-
tively. Proteins were ﬁnally eluted in 0.5 CV fractions using an elution
buffer containing 300 mM imidazole. Expression and puriﬁcation of
the negative control samples was performed identically.
3. Results
3.1. Design of the fusion proteins
Structural characterization of proteins by NMR requires high and
robust protein expression levels, and should ideally also include the
possibility for perdeuteration. As a result, expression of labeled pro-
tein is almost exclusively done in E. coliwhere the protein is produced
to high levels in inclusion bodies. Subsequent refolding is required to
obtain well-folded material. Unfortunately, this robust strategy is
often not successful for alpha-helical membrane proteins due to the
difﬁculties in refolding them in a functional form [12,13]. To some ex-
tend the formation of inclusion bodies can be avoided by decreasing
the expression rate, e.g., by lowering the cultivation temperature or
using a weaker promoter, thus allowing expression in the membrane
in a folded state [29].
To determine which fragments of the Y4 receptor were amenable to
overexpression in a folded state, we created a set of six truncation mu-
tants from the N-terminus and a set of six truncation mutants from the
C-terminus, differing in length by multiples of single alpha-helices
(Fig. 1). To allow for correct processing by the membrane protein
insertion machinery, for each fragments starting with a residue
that was expected to be on the outside of the cell based on a structural
model, the N-terminus was fused to Lep or Mistic. Lep adopts a well-
characterized Nout-Cout topology, while for Mistic, a protein from Bacillus
subtilis that associates tightly with the membrane, the topology is less
well deﬁned (vide infra). However, Mistic has been suggested to facilitateFig. 2. Membrane topology of Mistic- and Lep-fusion of Y4 GPCR fragments as determined wit
with a cytoplasmic, periplasmic or mixed location of their C-terminus, respectively. EmrE* den
activities (white bars) based on biological triplicates were normalized and plotted in pairs forand enhance expression of both membrane proteins with an Nout or
Nin topology [20–22]. For this reason, we also fused Mistic to frag-
ments with a proposed cytoplasmic N-terminus. We observed that
without Lep or Mistic fusions, fragments localize in the inclusion bodies
when expressed in E. coli [30].
Lacking a functional assay to determine the speciﬁc activity of the
fragments, we used the membrane topology as an initial indicator for
a correct folding state. As reporters for a cytoplasmic or periplasmic
location of the C-terminus, the well-established topology indicators
GFP and PhoA were used [18,31]. These indicator proteins were
fused to the C-terminus of each fragment. Only GFP located in the cy-
toplasm will become ﬂuorescent as it remains “dark”when expressed
in the periplasm. In contrast, only PhoA expressed in the periplasm
will mature and become functional while cytoplasmic PhoA remains
inactive if cultivation is limited to several hours [28]. In addition to this,
GFP is used as a reporter for protein folding as well [18,29,32]. Since
the GFP signal reports both folding and topology, it potentially compli-
cates the analysis. Nevertheless a good agreement has been found be-
tween membrane topology models determined by PhoA/GFP reporter
fusions and the corresponding high-resolution 3D structures [33–38].
Possibly, the PhoA fusion protein reports on folding as well to a similar
extend as GFP does.
Except for PhoA, all N- and C-terminal fusion proteins were sepa-
rated from the Y4 receptor fragments by a 3C protease site to allow
future analysis of the fragment only. All combinations of Y4 fragments
and different N- and C-terminal fusion partners, amounting to 46 dif-
ferent constructs, were expressed in the same E. coli strain, SF100.
This strain is compatible with both GFP and PhoA assays [26].
3.2. Topology of the Y4 receptor fragments
For each Y4-fragment, we determined the PhoA activity and the
GFP ﬂuorescence of the corresponding fusion proteins using biologi-
cal triplicates (Fig. 2A). Constructs displaying high GFP ﬂuorescence
and low PhoA activity are indicative of membrane proteins with ah the PhoA/GFP reporter assay. LacS, Lep and EmrE* represent control membrane proteins
otes the R29G/R82S double-mutant of EmrE. A) GFP ﬂuorescence (black bars) and PhoA
each individual construct. B) log (PhoA/GFP) values for each individual construct.
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low GFP ﬂuorescence are indicative of a periplasmic localization of
the C-terminus. Mixed or dual topology is characterized by proteins
displaying both signiﬁcant GFP and PhoA signals. To validate our
setup, we made use of three proteins for which the location of the
C-terminus had been determined previously. LacS is a transport pro-
tein with twelve TM segments and a cytoplasmic C-terminus [39].
Lep contains the ﬁrst two TM segments preceding the periplasmic do-
main of the membrane-bound protease Leader Peptidase [19]. Next to
these membrane proteins with one clear topology, we used EmrE as
an example of a protein with a dual topology. More speciﬁcally, we
used EmrE(R29S/R82S) as this mutant shows a more similar popula-
tion of both topologies compared to wild-type EmrE. The dual topol-
ogy of EmrE has been shown to be essential for its activity [27].
We observed high GFP ﬂuorescence for LacS and high PhoA activity
for Lep as expected for membrane proteins with a Cin or Cout topology,
respectively. In contrast, EmrE(R29S/R82S) displayed intermediate
values (Fig. 2A). Taken together, these results conﬁrmed the predic-
tive value of the GFP/PhoA reporter assay. We subsequently analyzed
Mistic as well to determine the preferred location of its C-terminus.
Though Mistic has been shown to facilitate the expression of proteins
with an Nout topology [22], our data indicate that Mistic not fused to
any Y4 fragment has its C-terminus located in the cytoplasm. To nor-
malize data, we arbitrarily set the high GFP ﬂuorescence of Mistic-GFP
and the high PhoA activity of the Lep-PhoA fusion protein to 1.
Fusions between Mistic and the Y4 receptor fragments generally
displayed higher GFP and PhoA signals than the corresponding Lep-
fusions, which is indicative of higher expression levels (Fig. 2A). For
bothMistic and Lep fusions, it was in general difﬁcult to unambiguously
assign a deﬁned topology, as often the difference in activities of both
reporter proteins was small. To correct for differences in the expression
levels of the different fusions, we plotted the ratio of the PhoA to GFP
signals for each fragment (Fig. 2B). A PhoA/GFP ratio of 1, or a Log(ratio)
of 0, in principle corresponds to a 1:1mixed topology (50% Cout and 50%
Cin). However, we like to emphasize that the PhoA/GFP assay is not
sufﬁciently quantitative to determine topology distributions in such
an exact fashion as the scaling of both axis is arbitrary. Fusions between
Mistic and Y4 fragments starting with TM1 showed an alternating
PhoA/GFP ratio with every extra TM segment (Fig. 2B). Constructs
with an odd number of TM segments display a low PhoA/GFP ratio,
whereas constructs with an even number of TM segments show a
higher PhoA/GFP ratio, in agreement with the expected topology for
GPCRs. In addition, for nearly every extra TM segment added, the topol-
ogy becomes more skewed toward one particular state, indicating
that the fraction of well-oriented fragments and thus the overall quality
of folding is improved in the longer constructs.
Interestingly, the opposite trend is observed for the fusions be-
tween Mistic and N- terminally truncated Y4 fragments. Here, short-
ening the constructs by progressively removing TM segments from
the N-terminus leads to a more clearly deﬁned Cin-topology. These ob-
servations suggest that the C-terminus rather than the N-terminus of
the protein is important for establishing the correct topology in the en-
tire receptor. Overall, similar trends were observed when using fusions
between Lep and Y4 fragments, though the differences in the PhoA/GFP
ratios were less pronounced compared to the Mistic-based fusions.
The average log PhoA/GFP ratio for the fusions of Mistic and Y4 frag-
ments starting with TM1 was lower (−0.44) than the average ratio of
the corresponding Lep fusions (+0.22). As all constructsweremeasured
under identical conditions, this suggests that either the Lep fusions
have a higher tendency for a periplasmic C-terminus, or the Mistic fu-
sions incline more toward a C-terminus located in the cytoplasm.
To conclude, our results indicate that most probably the Y4 frag-
ments studied here exist as mixtures of proteins with correct and in-
correct locations of the C-terminus. However, the distribution of the
topologies is not random. For the Y4 fragments starting with TM1 a
clear trend in the PhoA/GFP ratio can be seen, suggesting an increasedpreference of the fragments toward the correct topology. Likewise,
most Y4 fragments ending with TM7 display comparably low PhoA/
GFP ratios in line with a correct location of the C-terminus in the cyto-
plasm. These data are indicative of a correct topology for a predominant
fraction of the material.
3.3. Puriﬁcation of individual fragments in fusion with Mistic
As the Mistic-fusions showed in general: 1) more pronounced dif-
ferences in the PhoA/GFP ratio suggesting a more deﬁned topology;
and 2) higher absolute PhoA- and GFP-signals suggesting higher ex-
pression levels, we selected only Mistic-Y4 fragments for further
analysis. Furthermore, we observed that expression of Mistic-Y4 frag-
ments affected cell growth less than the corresponding Lep-fusions
resulting in approximately ﬁve-fold higher ﬁnal cell densities (data
not shown).
We selected the Mistic-Y4 fragment complementation pairs TM1–
3 plus TM4–7, and TM1–5 plus TM6–7 for further analysis based on
their pronounced PhoA/GFP ratios, and comparably high expression
levels. The fragments were expressed identically as for the topology
assay to assure that the quality of the material was not affected. All
fragments contained a C-terminal His-tagged GFP to facilitate detec-
tion and puriﬁcation. As stability of puriﬁed membrane proteins de-
pends strongly on the detergent used for solubilization, we screened
four different detergents for their efﬁciency to solubilize these frag-
ments. The detergents DDM and C12E8 are commonly used for crystalli-
zation of membrane proteins [40]. The detergents DPC and LMPC were
selected since they have proven to be particularly useful for NMR spec-
troscopy [41–43]. We comparedwhole cell lysates solubilized in the re-
spective detergents with the supernatant of the same lysate after
ultracentrifugation (Fig. 3C). Provided solubilization is successful, the
intensities of the GFP signal before and after centrifugation are expected
to be equal. In contrast, aggregation or incomplete solubilization will
reduce the GFP signal in the supernatant after centrifugation, as the in-
soluble material will pellet. Using DDM and C12E8, all four selected frag-
ments and the full-length receptor were completely removed from the
solubilizationmixture, indicating poor stability and/or incomplete solu-
bilization using these detergents. LMPC only solubilized a fraction of the
Y4 receptor fragments. Detergent-solubilization tests indicated that
only DPC was able to quantitatively recover the fragments (Fig. 3C).
DPC is generally known for its high efﬁciency in solubilizingmembrane
proteins [12,40,44], but in addition has been shown to solubilize even
misfolded membrane proteins [29]. In contrast, DDM, a mild detergent
that tends to selectively solubilize well-foldedmembrane proteins [29],
did not solubilize the fragments. Though this preference for DPC could
be related to the folding state, there are many examples of membrane
proteins with distinct preferences for certain detergents, and this prop-
erty could be a peculiarity of these fragments as well.
Using DPC we were able to purify the four fragments and the full-
length receptor to ~90% purity by IMAC (Fig. 3A). We obtained ap-
proximately 3–5 mg of each Y4 receptor fragment per liter of culture.
For all the fragments two major bands were observed with a differ-
ence in molecular weight of 10–15 kDa. Only the lower band was
ﬂuorescent (Fig. 3B). This dual migration behavior has been observed
before and has been correlated to a well-folded fraction, represented
by the ﬂuorescent band with a higher electrophoretic mobility, and a
fraction of aggregated material, represented by the non-ﬂuorescent
bandwith lower electrophoreticmobility [29]. However, here the signal
of the GFP reports not only on the folding quality of the fragments, but
on their membrane topology as well. Like aggregated protein, protein
inserted in the opposite topology is likely to be misfolded and not
expected to solubilize efﬁciently nor show similar migration properties
as well-folded protein. To verify whether a fraction of the protein is
indeed not in a well-folded state, or whether the non-ﬂuorescent
GFP-fusions represented a fraction folded but misoriented fusion
proteins, we analyzed the Y4 receptor fragments by size exclusion
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identical migration for both ﬂuorescent and non-ﬂuorescent GFP-
fusion protein suggesting that both species do have a similar stable
folding state (Fig. 3B). Only a fraction of the material was aggregated
and eluting in the void fraction (Suppl. Fig. 1). The remaining protein
migrated in a broad oligo-disperse peak of which the peak fraction
proved quite stable. Upon reinjection of this peak fraction, one rela-
tively broad single peak was obtained (Fig. 3D).
Further analysis of the Y4-fragments by NMR would require re-
moval of the fusion partners as these would complicate the analysis
of the NMR spectra and introduce undesired heterogeneity. For this
purpose, both Mistic and GFP were connected to the Y4 fragments
by a 3C protease cleavage site. Digestion of the puriﬁed fusion pro-
teins with the 3C protease readily cleaved of the GFP moiety, but
was very inefﬁcient in cleaving the protease site between Mistic and
the Y4-fragments (data not shown). Addition of a second 3C protease
site between Mistic and the Y4 fragments resulted in a virtually com-
plete digest (Suppl. Fig. 2).Fig. 3. Puriﬁcation of selected fragments of the Y4 GPCR. A) SDS-PAGE analysis of single frag
non-ﬂuorescent and ﬂuorescent species of the puriﬁed constructs, respectively. B) In gel GF
indicate the ﬂuorescent target band. C) Differential sedimentation of the Mistic- and GFP-fus
and solubilized with 1% DDM, 1% C12E8, 1% DPC, or 1% LMPC. T and S represent samples take
D) SEC of reinjected peak fractions from a previous run (Suppl. Fig. 1).3.4. Co-puriﬁcation of complementing Y4-fragment pairs
To simplify resonance assignments in the NMR analysis, the Y4
GPCR fragments should be produced separately to allow differential
isotopic labeling. This can be done by inducing proteins production
at different stages of cells growth [45]. To determine whether the
selected complementing Y4-fragmentswould in principle be able to sta-
bly interact, we co-expressed the complementary pairs TM1–3 plus
TM4–7 and TM1–5 plus TM6–7. All fragments were expressed as
N-terminal Mistic and C-terminal GFP fusions. Only fragment TM1–3
and TM1–5 additionally contained a C-terminal decaHis-tag.
For both complementation pairs, co-expression of both subunits was
succesfull based on in gel detection of GFP ﬂuorescence (Fig. 4, lane
SOL). The solubilized fragments were subsequently puriﬁed by IMAC.
As only one of the subunits contained a His-tag, speciﬁc co-puriﬁcation
of the complementing fragment would be a strong indication for signif-
icant afﬁnity of both fragments for each other. To ensure speciﬁc co-
puriﬁcation, the IMAC column was washed extensively. For bothments puriﬁed in 5 mM DPC using IMAC and SEC. White and black arrows indicate the
P ﬂuorescence of the gel depicted in panel A prior to Coomassie staining. Black arrows
ions analyzed by in gel ﬂuorescence. Whole cell lysates were disrupted by bead beating
n before (total protein) and after (solubilized protein) ultracentrifugation, respectively.
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fragment with the His-tagged fragment (Fig. 4, lane Elu). Notably, for
each complementation pair the GFP intensity ratio in the solubilization
fraction and the elution fractions was clearly changed toward a de-
creased signal for the untagged Y4 fragment. This was most prominent
for the TM1–3 plus TM4–7 pair. The decrease of the GFP signal of
the untagged subunits suggested that only a part of the fragments is
engaged in a stable interaction. This could be related to our previous ob-
servation that the heterologously expressed Y4 fragments are not uni-
form in the sense that multiple topologies coexist, though the correct
topology predominates. Furthermore, the afﬁnity of the complementing
fragment might not sufﬁce for complete retention of the untagged frag-
ment. Moreover, a control experiment in which only the untagged
subunit was puriﬁed, did not reveal its presence in the elution fractions
(Fig. 4, right side). This suggests that the presence of the untagged frag-
ments in the elution fractionsmust indeed result from tight interactions
of complementary fragment pairs.4. Discussion
Structural characterization of membrane proteins by NMR is still
in its infancies despite signiﬁcant recent progress (reviewed in
[46,47]). In order to enable studies of larger membrane proteins, we
are presently exploring alternative approaches using large fragments
of the human Y4 GPCR as a model system for two purposes: ﬁrst, we
intend to obtain structural data on these fragments to learn about the
assembly of the TM bundle and to obtain chemical shift assignments
that may be useful when studying the entire receptor; second, we plan
to split the entire receptor into two large fragments that will be pro-
duced separately to allow individual isotope-labeling schemes. Upon
subsequent mixing the fragments should reconstitute into a fully func-
tional receptor, for which resonance assignments are facilitated because
only part of the protein is labeled. Complementation approaches have
been pursued before for rhodopsin [48], the β-adrenergic [49] and the
Ste2p receptors [50]. These studies showed that functional receptors
could be reconstituted upon co-expression of fragments in eukaryotic
cells. To the best of our knowledge, the production of interacting GPCR
fragments in prokaryotic cells has not been reported so far.Fig. 4. Co-puriﬁcation of complementing Y4 GPCR fragments pairs. A) Samples taken at diff
and Mistic-TM4–7-GFP (labeled Test) or Mistic-TM4–7-GFP alone (labeled Negative contro
Mistic-TM1–5-GFP-His tag andMistic-TM6–7-GFP (labeled Test) or Mistic-TM6–7-GFP alone
by in gel GFP ﬂuorescence and Coomassie staining, respectively. Labels refer to marker (M)
third wash (W3), fourth wash (W4) and elution (ELU). The position of the ﬂuorescent fracHerein we constructed an extensive set of expression vectors for Y4
receptor fragments truncated from the N- or C-terminus thereby cover-
ing each possible combination of complementary fragments (Fig. 1). To
ensure an appropriate location of the N-terminus and to enhance pro-
tein expression levels, we fused the N-termini of the fragments to either
Lep or Mistic. In addition, we determined the quality of the fragments
expressed. Though protein quality is preferably assessed by determin-
ing speciﬁc activities, this approach is here not feasible as the fragments
do not posses any function. As an alternative, here we rapidly probed
the folding quality of the fragments on a basic level by analyzing their
topology within the context of a biological membrane.
For both Lep- and Mistic-fusions starting with TM1, we observed
an increase in the PhoA/GFP ratio with fragments containing an even
number of TM segments, and a decrease in the ratio for fragments
with an odd number, in agreement with their predicted periplasmic
and cytoplasmic orientations (Fig. 2B). Despite the appropriate trends
of the PhoA/GFP ratios, their absolute values mostly span a range in
between those of proteins with a clear Cin or Cout topology such as
LacS or Lep. This suggests that for most fragments both properly orient-
ed and misoriented species co-exist. Nevertheless, a clear preference
for the correct topology could be observed, providing an early indication
that a signiﬁcant fraction of the material was correctly folded in the
membrane.
Next to this, we observed that the Y4 fragments adopted a less
mixed topology if the C-terminal TM segments represented a larger
fraction of the Y4 fragment (Fig. 2B). This suggests that the C-terminal
part of the Y4 GPCR has a larger inﬂuence on adopting the predicted
topology than the N-terminus. Hessa et al. established a biological
scale for determining the propensity of a TM segment to insert in a bio-
logical membrane based on its amino acid sequence [51]. This scale
considers the TMsegments as isolated helices and thereby explicitly ne-
glects the contributions from interhelical interactions. In addition, the
preferred orientation of the TM segments in the membrane correlates
strongly to the amount of positive charges in the connecting loops
(positive-inside rule, [52]). The distribution of charges in the loops
of the Y4 GPCR is conform to the positive-inside rule (Fig. 5A). Im-
portantly, the calculated propensities for the TM segments of the
Y4 GPCR using the biological partitioning scale are in agreement
with our observations (Fig. 5B). The N-terminal TM segments areerent stages of the puriﬁcation from membranes containing Mistic-TM1–3-GFP-His tag
l). B) Samples taken at different stages of the puriﬁcation from membranes containing
(labeled Negative control). Upper and lower panels indicate the same gel after imaging
, solubilized membranes (SOL), ﬂow though (FT), ﬁrst wash (W1), second wash (W2),
tion of the protein is indicated by white and black arrows.
Fig. 5. Charge distribution in loops and calculated insertion propensities for individual
TM segments of the Y4 GPCR. (A) Net charge of all Y4 GPCR loops. (B) Free energies for
transferring entire TM segments into the membrane using a biological scale [51].
Amino acid sequences of the TM helices are indicated in Suppl. Table 2.
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require interhelical interactions for proper membrane insertion. Their
weak propensity to insert may explain the multiple topologies of TM1
up to TM1–3 as derived from the GFP/PhoA ratios. Interestingly, our re-
cent studies of the Y4 TM1-TM2 fragment in amodelmembrane system
(LPPG micelles) using NMR techniques also revealed that secondary
structure in the helices is not stably formed, and that both helices do
not fully integrate into the micelles [53]. In contrast, TM segments
in the C-terminal half of the receptor have a larger propensity to
insert into the membrane and thereby may help in stabilizing the
N-terminal TM segments in a hydrophobic environment. As a result,
the mixture of topologies is skewed toward their native orientation
resulting in PhoA/GFP ratios reﬂecting more unique topologies.
Though the use of Mistic- and Lep-fusions to the N-terminus of
fragments with a predicted Nout topology provided qualitatively similar
results, a few important differences were noted. First, only the Mistic-
fusions expressed at levels compatible with economical production of
isotope-labeled protein (3–5 mg protein after IMAC/liter culture), in
agreement with previous observations [22,54]. Second, the average
PhoA/GFP ratios for the Mistic- and Lep-fusions differed greatly: Lep-
fusions displayed higher average PhoA/GFP ratio than Mistic-fusions
(Fig. 2A). As the PhoA and GFP signals cannot be directly compared,
it is not possible to speciﬁcally attribute this difference to a higher aver-
age PhoA activity for Lep-fusions or a higher average GFP-activity for
Mistic-fusions. It is however in linewith the preferred topologies deter-
mined for the fusion proteins alone (Cout for Lep, Cin for Mistic).
Based on the high expression levels and on the PhoA/GFP ratios
that suggested a signiﬁcant fraction of protein with a proper foldingstate, we selected the Mistic- and GFP fusions of the complementa-
tion pairs TM1–3 plus TM4–7, and TM1–5 plus TM6–7 for further
analysis. These fragments were expressed well in E. coli and could
be solubilized efﬁciently in DPC detergent. The puriﬁed proteins proved
to be stable in detergent. Moreover, the fusion proteins could be re-
moved using the 3C protease, although in case of Mistic two 3C sites
were required for proper processing.
Though the puriﬁed Y4 GPCR fragments showed good stability
upon reinjection of the main SEC peak, the mixed topologies, the re-
quirement for DPC, the dual migration of the GFP-fusions and the
broad peak during the initial analysis by SEC raised concerns about
the folding state of the protein produced. To determine whether the
selected complementing Y4-fragments are in principle able to stably
interact, the complementation pairs TM1–3 plus TM4–7 and TM1–5
plus TM6–7 were co-expressed. Upon puriﬁcation, we observed spe-
ciﬁc co-elution of the untagged TM4–7 and TM6–7 with their respec-
tive His-tagged complementation partners TM1–3 and TM1–5. This
suggests that at least a signiﬁcant fraction of these Y4 GPCR fragments
is in a state that allows a strong physical interaction with its comple-
mentation partner. Our topological study suggests that the fragment
starting with the N terminus is better folded the longer it is, and
hence the TM1–5 fragment is expected to be preferable over the
TM1–3 fragment. Our co-puriﬁcation data indicate that this is indeed
the case. We conclude with the statement that our study suggests that
producing complementary fragments presents a promising route to
obtain a reconstituted receptor that can be a useful system for simplify-
ing its spectroscopic characterization by NMR.
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